HLA complement markers in Italian narcoleptic patients with special emphasis on BfF subtyping
Summary
Narcolepsy patients, particularly those of Mediterranean origin, share specific human leukocyte antigen (HLA) phenotypes, including DR2 and DQW2. These findings suggest a complex genetic basis for narcolepsy beyond a single HLA type.
Area of Science:
- Immunogenetics
- Neurology
- Human Leukocyte Antigen (HLA) Polymorphisms
Background:
- Narcolepsy is a complex sleep disorder with suspected genetic underpinnings.
- Previous studies indicated a strong association between narcolepsy and specific HLA phenotypes, particularly in Caucasian populations.
Purpose of the Study:
- To investigate human leukocyte antigen (HLA) polymorphisms in narcoleptic patients of Mediterranean origin.
- To explore potential genetic heterogeneity within the narcolepsy patient cohort.
- To examine the association of specific HLA phenotypes and complotypes with narcolepsy.
Main Methods:
- Human leukocyte antigen (HLA) typing was performed on 30 narcoleptic patients, with a focus on Mediterranean individuals.
- Analysis included HLA class I and class III polymorphisms, as well as complotyping (Bf, C4A, C4B).
- Isoelectric focusing was used to detect specific subtypes, such as the Fb subtype.
Main Results:
- A significant association was observed between narcolepsy and the DR2, DQW2 HLA phenotype in the studied cohort (p < 0.0001).
- The complotype BfS, C4A3, C4B1 was also characteristic of these patients.
- A single patient of Black origin exhibited a distinct HLA profile (DR3,5; DQW2,W3; C4A4,4; C4B1,2), challenging the sole involvement of the DR2, DQW1 phenotype.
Conclusions:
- The DR2, DQW2 phenotype and specific complotypes are strongly associated with narcolepsy, even in Mediterranean populations.
- The distinct genetic profile of the Black patient suggests that narcolepsy's genetic etiology may involve multiple HLA associations or other genetic factors.
- No significant genetic heterogeneity was identified based on clinical features within this cohort.


